Sucampo Pharmaceuticals Inc

Visual Financials
Company Name: Sucampo Pharmaceuticals Inc
Ticker Symbol: SCMP
CIK Number: 0001365216
WWW Address: http://www.sucampo.com
CEO: Mr. Peter S. Greenleaf
No. of Employees: 139
Common Issue Type: CS
Business Description:Sucampo Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 18.0 Unchanged 0.0 18.0 18.0  18.08 17.95 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 839.5 46.6 0.00 0.43 0.00 24.4 0.0 18.75 - 9.30
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close18.00$
PE Ratio - LTM24.4
Market Capitalisation839.5mil
Latest Shares Outstanding46.6mil
Earnings pS (EPS)0.43$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee1,655,079$
Effective Tax Rate0.0%
Float22.4mil
Float as % of Shares Outstanding0.5%
Foreign Sales90mil
Domestic Sales140mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.20%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin67.0%
EBITDA Margin36.4%
Pre-Tax Profit Margin0.0%
Assets Turnover47.0%
Return on Assets (ROA)3.8%
Return on Equity (ROE)14.6%
Return on Capital Invested (ROCI)10.6%
Current Ratio9.5
Leverage Ratio (Assets/Equity)3.1
Interest Cover1.6
Total Debt/Equity (Gearing Ratio)1.74
LT Debt/Total Capital63.0%
Working Capital pS5.89$
Cash pS0.00$
Book-Value pS0.85$
Tangible Book-Value pS-0.73$
Cash Flow pS0.63$
Free Cash Flow pS0.62$
KEY FIGURES (LTM): Price info
Price/Book Ratio12.59
Price/Tangible Book Ratio0.00
Price/Cash Flow17.0
Price/Free Cash Flow17.2
P/E as % of Industry Group301.0%
P/E as % of Sector Segment233.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.121,265,101479,010
4 Weeks18.3017.8518.05-0.341,585,62831,712,571
13 Weeks18.7510.1010.3573.9712,526,669154,126,843
26 Weeks18.759.4510.5071.4641,487,062185,882,817
52 Weeks18.759.3011.7553.2401,027,506257,904,140
YTD18.7517.85-0.622,111,73761,240,401
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
17.9817.9617.5013.0812.340.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.330.60.37
Income0.00.42
Dividend0.0
Capital SpendingNA
R&D0.00NA0.00
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %17.117.148.8
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.03-0.030.53
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio35.70
Current Ratio9.5
Quick Ratio (Acid Test)8.3
Liquidity Ratio (Cash)3.08
Receivables Turnover7.0
Average Collection Period51
Working Capital/Equity188.8
Working Capital pS3.51
Cash-Flow pS0.19
Free Cash-Flow pS0.16
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.07
Financial Leverage Ratio (Assets/Equity)1.7
Debt Ratio55.2
Total Debt/Equity (Gearing Ratio)1.74
LT Debt/Equity1.74
LT Debt/Capital Invested83.4
LT Debt/Total Liabilities84.5
Interest Cover1.6
Interest/Capital Invested6.44
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.09
Current P/E Ratio - LTM24.40
Enterprise Value (EV)/EBITDA7.13
Enterprise Value (EV)/Free Cash Flow64.52
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM12.59
Price/Cash Flow Ratio17.0
Price/Free Cash Flow Ratio - LTM17.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM107.9
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-8.9
5-Y Low P/E Ratio-1.3
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group301.0
P/E as % of Sector Segment233.0
Current 12 Month Normalized P/E Ratio - LTM80.4
PER SHARE FIGURES
LT Debt pS9.90
Current Liabilities pS4.09
Tangible Book Value pS - LTM-0.73
Book Value pS - LTM0.85
Capital Invested pS7.26
Cash pS - LTM0.00
Cash Flow pS - LTM0.63
Free Cash Flow pS - LTM0.62
Earnings pS (EPS)0.43
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin3.08
Free Cash Flow Margin 5YEAR AVG8.52
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity2.66
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.68
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.50
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin67.0
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM36.4
EBIT Margin - LTM16.6
Pre-Tax Profit Margin0.2
Pre-Tax Profit Margin - 5YEAR AVRG.0.2
Effective Tax Rate45.3
Effective Tax Rate - 5YEAR AVRG.21.9
EFFICIENCY RATIOS
Cash Conversion Cycle873,226
Revenue per Employee1,655,079
Net Income per Employee133,000
Average Collection Period873,226
Receivables Turnover7.0
Day's Inventory Turnover Ratio
Inventory Turnover2.7
Inventory/Sales14.4
Accounts Payble/Sales21.86
Assets/Revenue2.00
Net Working Capital Turnover1.41
Fixed Assets Turnover1.12
Total Assets Turnover0.5
Revenue per $ Cash2.12
Revenue per $ Plant35.99
Revenue per $ Common Equity2.66
Revenue per $ Capital Invested0.68
Selling, General & Adm/tive (SG&A) as % of Revenue20.1
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue20.3
R&D Expense as % of Revenue - 5YEAR AVRG.20.3

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.